Uplift Appoints New Chief Strategy Officer
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2026
0mins
Should l Buy CVSA?
Source: Newsfilter
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVSA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVSA
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 114.030
Low
Averages
High
Current: 114.030
Low
Averages
High
About CVSA
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
Insider Buying Analysis: Alpha Metallurgical and Covista
- Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
- Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
- Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
- Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
See More
Uplift Appoints New Chief Strategy Officer
- Executive Appointment: Uplift has appointed Evan Trent as Chief Strategy Officer, who will lead the firm's M&A and Integration Value Creation Center from Chicago, expected to enhance the value creation capabilities of portfolio companies through strategic M&A and transformation initiatives.
- Extensive Experience: With over 25 years in the industry, Trent has held multiple senior leadership roles at Covista, where he successfully led major acquisitions and business transformations, providing Uplift with valuable expertise and practical insights for strategic deployment.
- Investment Strategy: Uplift's investment strategy is built on a unique '5-5-5 Framework' targeting companies across five business models and five service sectors, aiming to achieve sustainable value creation through optimized organizational design and go-to-market strategies.
- Market Expansion: Trent's appointment is seen as a significant step for Uplift at this formative stage of growth, with Managing Partner Brad Skaf noting that Trent's experience will aid in institutionalizing and scaling the firm's approach to value creation, thereby enhancing its competitive position in the market.
See More
